Meeting
2017 ASCO Annual Meeting
Is surgical resection beneficial in recurrent or metastatic gastric cancer?
Authors
Yong Won Choi
Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, South Korea
Yong Won Choi , Mi Sun Ann , Hyun Woo Lee , Seok Yun Kang , Jin-Hyuk Choi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 4043)
DOI
10.1200/JCO.2017.35.15_suppl.4043
Abstract #
4043
Poster Bd #
35
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The optimal extent of lymph node dissection for gastric cancer with para-aortic lymph node metastases.
First Author: Takeyuki Wada
Poster
2015 Gastrointestinal Cancers Symposium
Do recurrent and de novo metastatic biliary tract cancer patients have the same outcome on treatment?
First Author: Mairead G McNamara
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Time to first treatment and optimal adjuvant treatment strategy in patients with resectable gastric cancer pathologically upstaged to lymph node–positive disease.
First Author: Pranay Shah Ajay
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Comparison of survival between de novo stage IV and recurrent stage IV gastric cancer.
First Author: Jun Ho Ji